In-vitro diagnostics (IVD): Tech trends for 2023

Widely used for detecting diseases, conditions, and infections, in-vitro diagnostics (IVD) has been witnessing several technological advances. What are these advancements in IVD and how will they play out in the near future? A report.

- MANJUSHA ANIL

In about 70 percent of all clinical decisions, in-vitro diagnostics (IVD) is a very important healthcare resource not only for disease detection but also for monitoring a patient's condition, deciding the line of treatment, seeing that the treatment is complete, or to decide whether there is a cure, or for prognosis.

In India, the laboratory and diagnostic business is at a crucial juncture, as it is changing from a profit-driven area to a customer-centric stream, and is in the course of becoming the soul of the healthcare sector, given the rising need of early detection and monitoring demanded today by several life-threatening diseases.

In recent times, there has been plenty of advances in the IVD space, whether at the genomics, the molecular diagnostics, the technology, instrumentation, materials used, or the software solution levels. The Covid-19 pandemic accelerated this advancement. The global in-vitro diagnostics (IVD) market size is projected to reach $96.0 billion by 2025 from $84.5 billion in 2020, according to a ResearchAnd Markets report. According to the same research firm, the India IVD (Instruments & Reagents) market is likely to reach $1.8 billion mark by 2025.

The emerging technologies

Thanks to the demands of the Covid era, polymerase chain reaction (PCR) testing has become mainstream with its ability to quickly churn out results using the same sample for multiple detections, informs Chandrashekhar Nair, Co-Founder and CTO, Molbio Diagnostics.